Premium
The efficacy of omeprazole twice daily with supplemental H 2 blockade at bedtime in the suppression of nocturnal oesophageal and gastric acidity
Author(s) -
Orr W. C.,
Harnish M. J.
Publication year - 2003
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1046/j.1365-2036.2003.01594.x
Subject(s) - bedtime , ranitidine , medicine , omeprazole , reflux , nocturnal , gastroenterology , gastric acid , placebo , anesthesia , stomach , disease , alternative medicine , pathology
Summary Background: It has been presumed that nocturnal acid breakthrough may pose a risk for the development of nocturnal gastro‐oesophageal reflux. Aim: To investigate the occurrence of gastro‐oesophageal reflux and acid breakthrough during polygraphically monitored sleep under conditions of powerful acid suppression with omeprazole 20 mg b.d. and an additional dose of ranitidine at bedtime. Methods: Nineteen individuals with symptomatic gastro‐oesophageal reflux disease were studied. Each individual was studied on two occasions subsequent to 1 week of 20 mg of omeprazole treatment b.d. Subjects underwent 24‐h oesophageal and gastric pH recording, with polysomnographic monitoring. Participants received either 150 mg ranitidine at bedtime or placebo, prior to a provocative meal. Results: Ranitidine administration resulted in a significant ( P < 0.01) reduction in the percentage of time the intragastric pH < 4.0. There was no significant difference with regard to measures of gastro‐oesophageal reflux, and reflux events were not noted to occur with a significantly greater frequency during periods of nocturnal acid breakthrough compared with control intervals without acid breakthrough. Conclusions: The administration of 150 mg ranitidine at bedtime did not significantly alter the occurrence of sleep‐related gastro‐oesophageal reflux.